300
Participants
Start Date
November 1, 2018
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2027
Involved field irradiation
Involved field irradiation; intensity-modulated radiation therapy
Elective field irradiation
Elective field irradiation; intensity-modulated radiation therapy
Paclitaxel
Paclitaxel 135-150mg/m2, d1, every 3 weeks
Platinum
for lobaplatin, 30mg/m2, d1-2, total dose should not exceed 50mg,every 3 weeks; for nedaplatin 50mg/m2, d1-2, every 3 weeks;
PEG-rhG-CSF
PEG-rhG-CSF 3-6mg, 48 hours after chemotherapy
RECRUITING
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing
The First Affiliated Hospital with Nanjing Medical University
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Anyang Tumor Hospital
OTHER
Fujian Cancer Hospital
OTHER_GOV
Peking University Cancer Hospital & Institute
OTHER
Hebei Medical University Fourth Hospital
OTHER
Chinese Academy of Medical Sciences
OTHER